ADMA BIOLOGICS, INC. Public Float
ADMA BIOLOGICS, INC. (ADMA) had Public Float of $4.23 billion as of 2025-06-30, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-25
- 2025-06-30: Entity Public Float $4.23B.
- 2024-06-30: Entity Public Float $2.54B.
- 2023-06-30: Entity Public Float $793.96M.
- 2022-06-30: Entity Public Float $372.62M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $4.23B 10-K · filed 2026-02-25 | |
| 2024-06-30 | $2.54B 10-K · filed 2025-03-18 | |
| 2023-06-30 | $793.96M 10-K · filed 2024-02-28 | |
| 2022-06-30 | $372.62M 10-K · filed 2023-03-23 | |
| 2021-06-30 | $173.22M 10-K · filed 2022-03-24 | |
| 2020-06-30 | $184.14M 10-K · filed 2021-03-25 | $158.69M 10-K · filed 2020-03-13 |
| 2018-06-30 | $133.16M 10-K · filed 2019-03-13 | |
| 2017-06-30 | $25.43M 10-K · filed 2018-03-29 | |
| 2016-06-30 | $40.90M 10-K · filed 2017-02-24 | |
| 2015-06-30 | $40.94M 10-K · filed 2016-03-23 | |
| 2014-06-30 | $29.87M 10-K · filed 2015-03-09 | |
| 2013-10-17 | $26.50M 10-K · filed 2014-03-28 | |
| 2012-12-31 | $0.00 10-K · filed 2013-03-06 | |
| 2012-08-13 | $4.65K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |